COMPANY
Helios Cardio
FDA-cleared device company Clinical Phase 2
Timeline
- Trial start Phase 1/Phase 2: Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06730828 | Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects | Phase 1/Phase 2 | Recruiting | Dec 16, 2024 | 2025-11 (estimated) |